The role of extracellular vesicles in pyroptosis-mediated infectious and non-infectious diseases.

Exosomes Extracellular vesicles Infectious diseases Non-infectious diseases Pyroptosis

Journal

International immunopharmacology
ISSN: 1878-1705
Titre abrégé: Int Immunopharmacol
Pays: Netherlands
ID NLM: 100965259

Informations de publication

Date de publication:
09 Jul 2024
Historique:
received: 06 04 2024
revised: 22 06 2024
accepted: 02 07 2024
medline: 11 7 2024
pubmed: 11 7 2024
entrez: 10 7 2024
Statut: aheadofprint

Résumé

Pyroptosis, a lytic and pro-inflammatory cell death, is important in various pathophysiological processes. Host- and bacteria-derived extracellular vesicles (EVs), as natural nanocarriers messengers, are versatile mediators of intercellular communication between different types of cells. Recently, emerging research has suggested that EVs exhibit multifaceted roles in disease progression by manipulating pyroptosis. This review focuses on new findings concerning how EVs shape disease progression in infectious and non-infectious diseases by regulating pyroptosis. Understanding the characteristics and activity of EVs-mediated pyroptotic death may conducive to the discovery of novel mechanisms and more efficient therapeutic targets in infectious and non-infectious diseases.

Identifiants

pubmed: 38986299
pii: S1567-5769(24)01154-8
doi: 10.1016/j.intimp.2024.112633
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

112633

Informations de copyright

Copyright © 2024 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Cai-Hua Zhang (CH)

School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou, Hubei 434023, China; Department of Oncology, People's Hospital Affiliated to Chongqing Three Gorges Medical College, Chongqing 404100, China.

Ding-Ci Lu (DC)

School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou, Hubei 434023, China.

Ying Liu (Y)

School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou, Hubei 434023, China.

Lingzhi Wang (L)

Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, 117600 Singapore; Cancer Science Institute of Singapore, National University of Singapore, 117599 Singapore; NUS Centre for Cancer Research (N2CR), National University of Singapore, 117599 Singapore. Electronic address: csiwl@nus.edu.sg.

Gautam Sethi (G)

Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, 117600 Singapore; NUS Centre for Cancer Research (N2CR), National University of Singapore, 117599 Singapore. Electronic address: phcgs@nus.edu.sg.

Zhaowu Ma (Z)

School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou, Hubei 434023, China. Electronic address: mazw@yangtzeu.edu.cn.

Classifications MeSH